The power of simulation in designing a pharmaceutical manufacturing process is due to the unique and detailed information it can provide for many operations. Learn more in this...
There are many factors that can affect medication access and initiation. With the power of AI and predictive analytics, patient support interventions can be optimized to allow...
Discover the power of Flow Imaging Microscopy in biopharmaceuticals. Learn how FIM works and how it can uncover details in your samples, enhancing the characterization of API ...
Supply chain challenges have long been a reality for pharma manufacturers, but the pandemic underscored the critical need for enhanced visibility and control. Added pressures,...
In the modern pharma landscape, packaging is more than just a protective barrier for drug products. Effective packaging ensures drug quality, complies with traceability regulations...
Enhance your bioproduction with Gibco™ Efficient-Pro™ Medium and Feed systems, achieving increased productivity in CHO-K1 and CHO-S cells. Experience reduced variability and superior...
Elevate your CHO cell culture productivity with the Gibco™ Efficient-Pro™ Medium and Feed System. Download our application note to explore how the Efficient-Pro™ Medium and Feeds...
Major players in the pharmaceutical industry are embracing digitalization – calibration processes, however, are still largely paper-based. This results in operational inefficiencies...
This article shares five top considerations when selecting a cell culture media supplier for a catalog medium or custom formulation manufacturing. Learn ways to maximize confidence...
Upholding rigorous quality standards is not only a regulatory imperative but also vital for ensuring the efficacy and safety of pharmaceutical products. And as many pharma manufacturers...
Nine out of 10 Fortune 500 executives surveyed expressed interest in the idea of outsourcing energy operations to reduce risk. Learn how an Energy as a Service model can support...
Discover how Blue Mountain's Regulatory Asset Manager (RAM) propelled AmplifyBio, a leading Contract Research Organization (CRO), into a paperless future.
mRNA-LNP manufacturing is fraught with obstacles, resulting in higher program risk, inflated costs, and delayed market release. With the right knowledge, companies can overcome...
During tableting processes, APIs become airborne. These dust particles can harm workers, reduce air quality, contaminate products and cause explosions. Learn how dust collectors...
High concentration mAbs can create challenges for subcutaneous injection, namely pain at the injection site. This peer-reviewed article compares buffer formulation options, and...
Effective viral clearance is at hand with the new, biodegradable J.T.Baker® Viral Inactivation Solution. A sustainable alternative to Triton X-100, this cGMP-ready solution supports...
Vacuum technology plays a crucial role in pharmaceutical processes (conveying, inertization, distilling, and drying). Using the most efficient vacuum technology can make these...
Learn more about how the innovation of chemically defined microbial media has created a new paradigm of microbial bioprocessing, one which has the potential to enhance the performance...
Challenges can arise when transitioning a media formulation from a non-cGMP prototype to a cGMP-manufactured product. Our case study outlines the scale-up process that was used...
Considering scalability, cost effectiveness, and convenience is essential to find a media format that can meet your current and future needs. Read our article to learn more about...
Scale-up is a critical stage, with an optimized medium and robust supply chains being central to consistent product quality and a cost-effective process. Read our article to discover...
A Contract Manufacturing Organization that produces and packages pharmaceuticals for customers which are then distributed in more than 150 countries found a solution to supply...
Discover five steps required to help create a compelling business case and get the key facts and figures you need to achieve senior buy-in for a digitalized QC Platform.
The U.S. is the largest pharmaceutical market by value and its drug spending has continued to outgrow the global market — and this is largely driven by biologics, which have seen...
The industry’s most established dosage forms, solid dose drugs are shelf stable and easy to administer. But today's drug formulations are complex and high potency, and OSD drugmakers...
Operational technology (OT) risks are on the rise, with more threat actors and incidents targeting manufacturers by the day. Even when organizations invest in preventative OT ...
Download this IDC InfoBrief to uncover key drivers and challenges pharma organizations face, as well as how investing in Edge Computing can help companies reach their operational...